Notice of Intent to Sole Source to GenScript

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to GenScript to scale-up their production of 100 mg of 15 one (1) Liter expression of High Yield, nine (9) 1.5 Liter expression of Medium Yield key chimeric antibodies, one (1) 2.5L expression of Low Yield chimeric antibodies, and production of 50 plasmids. This contract action is for products for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. The NAICS code for this acquisition is 423490. This notice of intent is not a request for competitive quotations. Any interested companies are welcome to submit their ability to provide the specified products within three (3) days of the issuance of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at [email protected] by 3pm EDT on August 16, 2021.